Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cannabis | 12 | 2024 | 447 | 4.140 |
Why?
|
Cannabinoids | 7 | 2021 | 174 | 2.880 |
Why?
|
Marijuana Abuse | 6 | 2020 | 409 | 1.790 |
Why?
|
Marijuana Smoking | 4 | 2020 | 261 | 1.550 |
Why?
|
Muscle Spasticity | 3 | 2017 | 159 | 1.460 |
Why?
|
Hallucinogens | 2 | 2022 | 212 | 1.190 |
Why?
|
Legislation, Drug | 4 | 2022 | 216 | 0.950 |
Why?
|
Opioid-Related Disorders | 7 | 2022 | 2188 | 0.880 |
Why?
|
Buprenorphine | 3 | 2022 | 667 | 0.780 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2022 | 69 | 0.760 |
Why?
|
Cocaine-Related Disorders | 11 | 2008 | 458 | 0.620 |
Why?
|
Cannabidiol | 1 | 2020 | 123 | 0.590 |
Why?
|
Psychiatry | 2 | 2021 | 1715 | 0.520 |
Why?
|
Opiate Substitution Treatment | 2 | 2022 | 452 | 0.500 |
Why?
|
Naloxone | 2 | 2015 | 372 | 0.490 |
Why?
|
Government Regulation | 1 | 2019 | 525 | 0.460 |
Why?
|
Drug Industry | 4 | 2009 | 791 | 0.420 |
Why?
|
Burnout, Professional | 1 | 2021 | 711 | 0.420 |
Why?
|
Subclavian Steal Syndrome | 1 | 2012 | 20 | 0.400 |
Why?
|
Emergency Medicine | 1 | 2021 | 1220 | 0.400 |
Why?
|
Tobacco Use Disorder | 3 | 2013 | 708 | 0.380 |
Why?
|
Alcoholism | 3 | 2013 | 1980 | 0.360 |
Why?
|
DiGeorge Syndrome | 1 | 2012 | 187 | 0.350 |
Why?
|
Nicotine | 2 | 2013 | 680 | 0.350 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2012 | 216 | 0.350 |
Why?
|
Neuralgia | 1 | 2015 | 619 | 0.310 |
Why?
|
Substance-Related Disorders | 5 | 2024 | 4422 | 0.300 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2009 | 103 | 0.300 |
Why?
|
Drug Approval | 1 | 2015 | 820 | 0.300 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2009 | 213 | 0.290 |
Why?
|
Psychotherapy | 5 | 2022 | 1653 | 0.290 |
Why?
|
Substance Abuse Detection | 3 | 2020 | 301 | 0.290 |
Why?
|
Sumatriptan | 1 | 2007 | 66 | 0.290 |
Why?
|
Risk | 2 | 2017 | 9606 | 0.290 |
Why?
|
Naproxen | 1 | 2007 | 101 | 0.280 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 982 | 0.280 |
Why?
|
Prolactin | 5 | 2008 | 627 | 0.280 |
Why?
|
Amphetamine-Related Disorders | 1 | 2007 | 80 | 0.270 |
Why?
|
Marketing | 1 | 2008 | 225 | 0.260 |
Why?
|
Gift Giving | 1 | 2006 | 76 | 0.250 |
Why?
|
Combined Modality Therapy | 5 | 2022 | 8535 | 0.250 |
Why?
|
Anxiety Disorders | 1 | 2017 | 2745 | 0.250 |
Why?
|
Biological Therapy | 1 | 2007 | 140 | 0.250 |
Why?
|
Serotonin | 4 | 2008 | 1045 | 0.240 |
Why?
|
Marketing of Health Services | 1 | 2006 | 151 | 0.240 |
Why?
|
Biomedical Research | 2 | 2019 | 3464 | 0.240 |
Why?
|
Vomiting | 2 | 2020 | 655 | 0.230 |
Why?
|
Humans | 62 | 2024 | 767040 | 0.230 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2004 | 28 | 0.230 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1188 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4629 | 0.230 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2004 | 46 | 0.220 |
Why?
|
Interview, Psychological | 1 | 2007 | 810 | 0.220 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 655 | 0.220 |
Why?
|
Nausea | 2 | 2019 | 682 | 0.220 |
Why?
|
Health Surveys | 2 | 2015 | 4056 | 0.220 |
Why?
|
Physicians | 1 | 2021 | 4593 | 0.220 |
Why?
|
Smoking Cessation | 2 | 2013 | 2085 | 0.220 |
Why?
|
Conflict of Interest | 1 | 2008 | 556 | 0.220 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2014 | 155 | 0.210 |
Why?
|
Analgesics, Opioid | 6 | 2022 | 3837 | 0.210 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1944 | 0.210 |
Why?
|
Narcotic Antagonists | 4 | 2015 | 591 | 0.210 |
Why?
|
Serotonin Receptor Agonists | 4 | 2008 | 151 | 0.200 |
Why?
|
Membrane Transport Proteins | 3 | 2003 | 1029 | 0.200 |
Why?
|
Cyclooxygenase 2 Inhibitors | 3 | 2009 | 319 | 0.200 |
Why?
|
Internship and Residency | 2 | 2021 | 5947 | 0.200 |
Why?
|
Lactones | 3 | 2009 | 315 | 0.200 |
Why?
|
Epilepsy | 1 | 2017 | 3317 | 0.200 |
Why?
|
Sulfones | 3 | 2009 | 447 | 0.190 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 5 | 2008 | 326 | 0.190 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 898 | 0.190 |
Why?
|
Policy | 2 | 2022 | 513 | 0.190 |
Why?
|
Vitamin B 12 | 1 | 2004 | 529 | 0.180 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 939 | 0.180 |
Why?
|
Ethics, Medical | 1 | 2006 | 785 | 0.180 |
Why?
|
Paroxetine | 5 | 2008 | 181 | 0.180 |
Why?
|
Endocarditis | 1 | 2024 | 352 | 0.170 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2020 | 627 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2270 | 0.140 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3702 | 0.140 |
Why?
|
Defense Mechanisms | 1 | 2017 | 178 | 0.140 |
Why?
|
Diabetic Neuropathies | 1 | 2021 | 409 | 0.140 |
Why?
|
Human Development | 1 | 2017 | 122 | 0.130 |
Why?
|
Pilot Projects | 4 | 2017 | 8732 | 0.130 |
Why?
|
Canada | 2 | 2019 | 2127 | 0.130 |
Why?
|
Analgesics | 2 | 2021 | 1071 | 0.130 |
Why?
|
Piperazines | 4 | 2008 | 2548 | 0.130 |
Why?
|
Behavior, Addictive | 2 | 2019 | 429 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2003 | 4925 | 0.130 |
Why?
|
Hypnotics and Sedatives | 1 | 2004 | 1193 | 0.130 |
Why?
|
Disease Progression | 1 | 2013 | 13646 | 0.120 |
Why?
|
Nerve Tissue Proteins | 3 | 2003 | 4401 | 0.120 |
Why?
|
Mental Health Services | 1 | 2007 | 1733 | 0.120 |
Why?
|
Family Relations | 1 | 2017 | 318 | 0.120 |
Why?
|
Cotinine | 2 | 2013 | 206 | 0.120 |
Why?
|
Social Adjustment | 1 | 2017 | 634 | 0.120 |
Why?
|
Migraine Disorders | 1 | 2007 | 1712 | 0.120 |
Why?
|
District of Columbia | 1 | 2014 | 159 | 0.120 |
Why?
|
Blood Platelets | 5 | 2008 | 2464 | 0.120 |
Why?
|
Syndrome | 1 | 2020 | 3271 | 0.110 |
Why?
|
Workplace | 1 | 2020 | 873 | 0.110 |
Why?
|
Alcoholics Anonymous | 1 | 2013 | 32 | 0.110 |
Why?
|
Wasting Syndrome | 1 | 2014 | 96 | 0.110 |
Why?
|
Adult | 24 | 2024 | 223317 | 0.110 |
Why?
|
Anesthesia | 1 | 2024 | 1595 | 0.110 |
Why?
|
Time | 1 | 2015 | 551 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 8048 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1009 | 0.100 |
Why?
|
Antiemetics | 1 | 2014 | 188 | 0.100 |
Why?
|
Residential Treatment | 1 | 2013 | 112 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10393 | 0.100 |
Why?
|
Receptors, Serotonin | 2 | 2003 | 210 | 0.100 |
Why?
|
Carbon Monoxide | 2 | 2013 | 559 | 0.100 |
Why?
|
State Government | 1 | 2015 | 388 | 0.100 |
Why?
|
Norwood Procedures | 1 | 2014 | 192 | 0.100 |
Why?
|
Bipolar Disorder | 2 | 2012 | 5130 | 0.100 |
Why?
|
Delirium | 1 | 2004 | 1698 | 0.100 |
Why?
|
Pyridines | 1 | 2004 | 2890 | 0.100 |
Why?
|
Female | 26 | 2024 | 396660 | 0.100 |
Why?
|
Behavior Therapy | 1 | 2017 | 886 | 0.090 |
Why?
|
Counseling | 2 | 2013 | 1553 | 0.090 |
Why?
|
United States | 7 | 2021 | 72971 | 0.090 |
Why?
|
Subclavian Artery | 1 | 2012 | 138 | 0.090 |
Why?
|
Multiple Sclerosis | 2 | 2017 | 3229 | 0.090 |
Why?
|
Health Education | 1 | 2018 | 1058 | 0.090 |
Why?
|
Narcotics | 1 | 2013 | 332 | 0.090 |
Why?
|
Withholding Treatment | 1 | 2015 | 619 | 0.090 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 715 | 0.090 |
Why?
|
Polymorphism, Genetic | 3 | 2007 | 4247 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 713 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2337 | 0.090 |
Why?
|
Mood Disorders | 1 | 2017 | 1129 | 0.090 |
Why?
|
Alcohol-Related Disorders | 1 | 2012 | 243 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3283 | 0.090 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2009 | 36 | 0.080 |
Why?
|
Male | 26 | 2024 | 364203 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.080 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2019 | 1498 | 0.080 |
Why?
|
Impulsive Behavior | 2 | 2019 | 345 | 0.080 |
Why?
|
United States Food and Drug Administration | 2 | 2015 | 1672 | 0.080 |
Why?
|
Cycloserine | 1 | 2009 | 118 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12986 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2004 | 3275 | 0.080 |
Why?
|
Ramipril | 1 | 2009 | 102 | 0.080 |
Why?
|
Deception | 1 | 2008 | 100 | 0.070 |
Why?
|
Sex Distribution | 1 | 2013 | 2276 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 2996 | 0.070 |
Why?
|
Age of Onset | 2 | 2013 | 3344 | 0.070 |
Why?
|
Tablets | 1 | 2007 | 149 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 881 | 0.070 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 196 | 0.070 |
Why?
|
Carbolines | 1 | 2009 | 288 | 0.070 |
Why?
|
Adolescent | 5 | 2021 | 89046 | 0.070 |
Why?
|
Amlodipine | 1 | 2007 | 84 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6215 | 0.070 |
Why?
|
Renin | 1 | 2009 | 647 | 0.070 |
Why?
|
GABA Agonists | 1 | 2007 | 106 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2662 | 0.070 |
Why?
|
Pituitary Gland, Anterior | 1 | 2006 | 142 | 0.070 |
Why?
|
Behavior | 2 | 2006 | 538 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2009 | 497 | 0.060 |
Why?
|
Disclosure | 2 | 2008 | 755 | 0.060 |
Why?
|
Ambulatory Care | 3 | 2013 | 2780 | 0.060 |
Why?
|
Aggression | 3 | 2006 | 748 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2009 | 2105 | 0.060 |
Why?
|
Research Support as Topic | 2 | 2008 | 697 | 0.060 |
Why?
|
Nicotinic Agonists | 1 | 2007 | 265 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1664 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5098 | 0.060 |
Why?
|
Sex Factors | 2 | 2013 | 10622 | 0.060 |
Why?
|
Authorship | 1 | 2008 | 289 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10582 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2836 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2021 | 65295 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2531 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1804 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2006 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 24299 | 0.060 |
Why?
|
Drive | 1 | 2003 | 34 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5101 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2015 | 1945 | 0.050 |
Why?
|
Patient Dropouts | 2 | 2002 | 411 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2698 | 0.050 |
Why?
|
Public Health | 1 | 2016 | 2681 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26325 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2009 | 839 | 0.050 |
Why?
|
Age Factors | 2 | 2013 | 18401 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1515 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5311 | 0.050 |
Why?
|
Mental Health | 1 | 2016 | 3272 | 0.050 |
Why?
|
Young Adult | 4 | 2017 | 59980 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8736 | 0.050 |
Why?
|
Risk-Taking | 1 | 2007 | 1023 | 0.050 |
Why?
|
Risk Factors | 3 | 2020 | 74886 | 0.050 |
Why?
|
Valproic Acid | 1 | 2004 | 444 | 0.050 |
Why?
|
Drug Combinations | 1 | 2007 | 2086 | 0.050 |
Why?
|
Publishing | 1 | 2008 | 837 | 0.040 |
Why?
|
Mental Disorders | 1 | 2020 | 6873 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2009 | 12451 | 0.040 |
Why?
|
Middle Aged | 8 | 2024 | 223233 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1205 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8890 | 0.040 |
Why?
|
Hydrocodone | 1 | 1999 | 48 | 0.040 |
Why?
|
Cinnamates | 1 | 1999 | 59 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 30238 | 0.040 |
Why?
|
Prospective Studies | 2 | 2017 | 54886 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13284 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2000 | 323 | 0.040 |
Why?
|
Receptors, Opioid, mu | 1 | 1999 | 167 | 0.040 |
Why?
|
Quality of Life | 2 | 2019 | 13485 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10748 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6310 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4713 | 0.040 |
Why?
|
Seasons | 1 | 2003 | 1523 | 0.030 |
Why?
|
Blood Pressure | 2 | 2009 | 8531 | 0.030 |
Why?
|
Radioligand Assay | 2 | 2008 | 365 | 0.030 |
Why?
|
Astrocytoma | 1 | 2000 | 773 | 0.030 |
Why?
|
Urban Population | 1 | 2003 | 2044 | 0.030 |
Why?
|
Patient Compliance | 2 | 2003 | 2697 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 2000 | 505 | 0.030 |
Why?
|
Motivation | 2 | 2020 | 2021 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2912 | 0.030 |
Why?
|
Outpatients | 1 | 2002 | 1600 | 0.030 |
Why?
|
Brain | 2 | 2019 | 27163 | 0.030 |
Why?
|
Heroin | 1 | 2014 | 120 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2004 | 1921 | 0.030 |
Why?
|
Injections, Intraventricular | 2 | 2007 | 227 | 0.030 |
Why?
|
Infant | 2 | 2014 | 36485 | 0.030 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2004 | 1389 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2008 | 1141 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1717 | 0.030 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2012 | 300 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36582 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3618 | 0.020 |
Why?
|
Reference Values | 3 | 2003 | 4918 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171319 | 0.020 |
Why?
|
North America | 1 | 2014 | 1287 | 0.020 |
Why?
|
Cocaine | 2 | 2006 | 944 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2421 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3683 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11513 | 0.020 |
Why?
|
Severity of Illness Index | 4 | 2008 | 15925 | 0.020 |
Why?
|
Breath Tests | 1 | 2009 | 297 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3431 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12069 | 0.020 |
Why?
|
Tritium | 1 | 2008 | 707 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2008 | 861 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2009 | 359 | 0.020 |
Why?
|
Binding Sites | 2 | 2008 | 6014 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2008 | 297 | 0.020 |
Why?
|
Extinction, Psychological | 1 | 2009 | 367 | 0.020 |
Why?
|
Self Administration | 1 | 2007 | 386 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1886 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 6067 | 0.020 |
Why?
|
Prognosis | 2 | 2002 | 29963 | 0.010 |
Why?
|
Cues | 1 | 2009 | 877 | 0.010 |
Why?
|
Palliative Care | 1 | 2019 | 3641 | 0.010 |
Why?
|
Hospitalization | 1 | 2004 | 10815 | 0.010 |
Why?
|
Reoperation | 1 | 2014 | 4325 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6513 | 0.010 |
Why?
|
Receptors, Drug | 1 | 2003 | 156 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7435 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15424 | 0.010 |
Why?
|
Philadelphia | 1 | 2003 | 270 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3773 | 0.010 |
Why?
|
Child Development | 1 | 2014 | 2329 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2000 | 4813 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2827 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9660 | 0.010 |
Why?
|
Personality Assessment | 1 | 2003 | 646 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 5042 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7121 | 0.010 |
Why?
|
Pennsylvania | 1 | 2002 | 615 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 2002 | 291 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14766 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2014 | 3305 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6489 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40154 | 0.010 |
Why?
|
Genotype | 2 | 2006 | 13035 | 0.010 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1999 | 19 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12536 | 0.010 |
Why?
|
Gene Frequency | 1 | 2006 | 3621 | 0.010 |
Why?
|
Membranes | 1 | 1999 | 164 | 0.010 |
Why?
|
Enkephalins | 1 | 1999 | 139 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3854 | 0.010 |
Why?
|
Personality Inventory | 1 | 2002 | 1018 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2000 | 616 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2000 | 9108 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8068 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 1999 | 361 | 0.010 |
Why?
|
Regression Analysis | 1 | 2008 | 6331 | 0.010 |
Why?
|
Neostriatum | 1 | 1999 | 231 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1168 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2000 | 913 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168965 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20169 | 0.010 |
Why?
|
Brain Edema | 1 | 2000 | 601 | 0.010 |
Why?
|
Heart Rate | 1 | 2007 | 4209 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 81659 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5796 | 0.010 |
Why?
|
Morphine | 1 | 1999 | 658 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 3813 | 0.010 |
Why?
|
Reaction Time | 1 | 1999 | 2086 | 0.010 |
Why?
|
Ligands | 1 | 1999 | 3273 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15824 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21526 | 0.010 |
Why?
|
Patient Care Team | 1 | 2000 | 2516 | 0.000 |
Why?
|
Pain Measurement | 1 | 1999 | 3584 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2006 | 22254 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2004 | 39317 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20741 | 0.000 |
Why?
|
Mice | 1 | 1999 | 81912 | 0.000 |
Why?
|